Magnolia and Illicium research
Magnolia and Illicium research is a research topic within Rehabilitation. Science Explorer counts 3.2k research works in it since 1951. 17.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the therapeutic applications of honokiol and magnolol compounds, derived from the Magnolia family. The research covers a wide range of potential uses, including anticancer, neuroprotective, anti-inflammatory, and antioxidative properties. These compounds have shown promising effects in inducing apoptosis, inhibiting angiogenesis, and serving as chemotherapy candidates for various diseases.
- Honokiol
- Magnolia Family
- Anticancer
- Neuroprotective
- Anti-inflammatory
- Antioxidative
- Apoptosis Induction
- Angiogenesis Inhibition
- Chemotherapy Candidate
- Natural Product
- Research works
- 3.2k fractional, since 1951
- In the world top 10%
- 545 per year above
- Top-10% rate
- 17.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +12% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Magnolia and Illicium research research?
By volume, China and India publish the most (349 and 31 works in 2022–2025).
By volume, 2022–2025
- 1 China 349 works
- 2 India 31 works
- 3 South Korea 27 works
- 4 United States 21 works
- 5 Japan 15 works
- 6 Iran 14 works
- 7 Taiwan 14 works
- 8 Poland 10 works
- 9 Türkiye 8 works
- 10 Italy 7 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Magnolia and Illicium research research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Magnolia and Illicium research research, followed by Nanjing University of Chinese Medicine and Chengdu University of Traditional Chinese Medicine.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 11 works
- 2 Nanjing University of Chinese MedicineChina 7 works
- 3 Chengdu University of Traditional Chinese MedicineChina 7 works
- 4 Shanghai University of Traditional Chinese MedicineChina 6 works
- 5 First Affiliated Hospital of Henan UniversityChina 4 works
- 6 Beijing University of Chinese MedicineChina 3 works
- 7 Tianjin University of Traditional Chinese MedicineChina 3 works
- 8 Zhejiang Chinese Medical UniversityChina 3 works
- 9 Shenyang Pharmaceutical UniversityChina 3 works
- 10 Sichuan UniversityChina 3 works
Where is Magnolia and Illicium research research done?
The largest centres of Magnolia and Illicium research research in 2022–2025 are Beijing (China), Guangzhou (China), Shanghai (China) and Chengdu (China). Among places with at least 20 works in it, it is an unusually large share of all research in Guangzhou.
Largest cities, 2022–2025
Where it is the local speciality
- GuangzhouCN · 22.8 works4.5×
Location quotient: how much more of its research is in Magnolia and Illicium research than the world average.
Where is the best place to study Magnolia and Illicium research?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 0.0 | 10.6% | 20.8× | 11 | -13.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Magnolia and Illicium research research growing?
Output in 2018–2022 was 12% higher than in 2013–2017, peaking in 2026. The fastest-growing topics are Magnolia and Illicium research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.